Knupfer S
Urologie. 2025; 64(2):120-127.
PMID: 39900843
DOI: 10.1007/s00120-024-02508-y.
Wright S, Ananthavarathan P, Simeoni S, Malladi P, Pakzad M, Panicker J
Int Neurourol J. 2024; 28(3):207-214.
PMID: 39363411
PMC: 11450239.
DOI: 10.5213/inj.2448176.088.
Frainey B, Clayton D
Front Pediatr. 2024; 12:1407009.
PMID: 38887561
PMC: 11180881.
DOI: 10.3389/fped.2024.1407009.
Rothlin K, Anding R, Seifert H, Hund-Georgiadis M, Mohr S, Walter M
Biomedicines. 2023; 11(11).
PMID: 38002018
PMC: 10669099.
DOI: 10.3390/biomedicines11113016.
Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B
Medicine (Baltimore). 2023; 102(S1):e32377.
PMID: 37499088
PMC: 10374192.
DOI: 10.1097/MD.0000000000032377.
The pluripotential evolution and journey of Botox (onabotulinumtoxinA).
Brin M, Blitzer A
Medicine (Baltimore). 2023; 102(S1):e32373.
PMID: 37499079
PMC: 10374190.
DOI: 10.1097/MD.0000000000032373.
Botox (onabotulinumtoxinA) mechanism of action.
Brin M, Burstein R
Medicine (Baltimore). 2023; 102(S1):e32372.
PMID: 37499078
PMC: 10374191.
DOI: 10.1097/MD.0000000000032372.
Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients-When Intravesical Botox Injection or Urethral Botox Injection Are Indicated.
Chen P, Lee K, Lee W, Yeh T, Kuo Y, Chiang B
Toxins (Basel). 2023; 15(4).
PMID: 37104226
PMC: 10145925.
DOI: 10.3390/toxins15040288.
Role of Urological Botulinum Toxin-A Injection for Overactive Bladder and Voiding Dysfunction in Patients with Parkinson's Disease or Post-Stroke.
Hu J, Hsu L, Lee W, Chuang Y, Wang H
Toxins (Basel). 2023; 15(2).
PMID: 36828479
PMC: 9965145.
DOI: 10.3390/toxins15020166.
Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?.
Chen S, Kuo H
Toxins (Basel). 2023; 15(2).
PMID: 36828402
PMC: 9967264.
DOI: 10.3390/toxins15020087.
Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection.
Kao Y, Ou Y, Tsai K, Kuo H
Toxins (Basel). 2022; 14(12).
PMID: 36548774
PMC: 9785547.
DOI: 10.3390/toxins14120877.
Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?.
Kuo H
Toxins (Basel). 2022; 14(7).
PMID: 35878235
PMC: 9324011.
DOI: 10.3390/toxins14070498.
Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia.
Huang Y, Chen S
J Rehabil Med. 2022; 54:jrm00264.
PMID: 35174865
PMC: 8963417.
DOI: 10.2340/jrm.v54.122.
BoNT/A in the Urinary Bladder-More to the Story than Silencing of Cholinergic Nerves.
Ibrahim H, Maignel J, Hornby F, Daly D, Beard M
Toxins (Basel). 2022; 14(1).
PMID: 35051030
PMC: 8780360.
DOI: 10.3390/toxins14010053.
Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.
Lee C, Jhang J, Jiang Y, Kuo H
Toxins (Basel). 2022; 14(1).
PMID: 35051007
PMC: 8777981.
DOI: 10.3390/toxins14010030.
Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.
Ou Y, Huang K, Jan H, Kuo H, Kao Y, Tsai K
Toxins (Basel). 2021; 13(6).
PMID: 34199493
PMC: 8226632.
DOI: 10.3390/toxins13060398.
Autonomic dysreflexia associated with cervical spinal cord gliofibroma: case report.
Mizuno H, Honda F, Ikota H, Yoshimoto Y
BMC Neurol. 2021; 21(1):252.
PMID: 34187375
PMC: 8240206.
DOI: 10.1186/s12883-021-02271-z.
Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders.
Jhang J, Kuo H
Toxins (Basel). 2021; 13(5).
PMID: 34069951
PMC: 8157602.
DOI: 10.3390/toxins13050359.
Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction.
Jiang Y, Chen S, Kuo H
Int Neurourol J. 2021; 24(4):301-312.
PMID: 33401351
PMC: 7788334.
DOI: 10.5213/inj.2040354.177.
Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA.
Ethans K, Casey A, Bard R, Namaka M
Degener Neurol Neuromuscul Dis. 2020; 4:65-75.
PMID: 32669901
PMC: 7337250.
DOI: 10.2147/DNND.S40349.